Follistatin vs MGF

Evidence-based comparison · Updated 2026

Summary

Follistatin and MGF target muscle growth through distinct mechanisms: Follistatin works systemically by inhibiting myostatin to remove a global brake on muscle protein synthesis, while MGF acts locally at the injection site to activate satellite cells and accelerate post-exercise repair. Researchers studying broad muscle hypertrophy tend to focus on Follistatin, while those examining localized repair and recovery lean toward MGF. Both carry a Grade C evidence rating and are classified as research-only compounds.

Side-by-Side Comparison

	Follistatin	MGF
Evidence	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data
Regulatory	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Benefits	+Inhibits myostatin +Dramatic increase in muscle mass +Increases strength significantly +May improve metabolic health +Reduces body fat	+Promotes localized muscle repair and growth +Enhances muscle protein synthesis post-exercise +Supports recovery from mechanical stress +Stimulates satellite cell activation +May improve muscle hypertrophy response
Dosage	100-300 mcg mcg — Every other day or 2x weekly	100-200 mcg — 1x daily
Route	Intramuscular	Subcutaneous
Category	Muscle Growth & Performance	Muscle Growth & Performance

Full research page

Follistatin →

Full research page

MGF →

Which Should You Choose?

Follistatin operates at a systemic level by neutralizing myostatin across skeletal muscle tissue, whereas MGF functions through paracrine signaling at the site of mechanical stress, making their applications meaningfully different in scope and timing.

Choose Follistatin when:

+Research goal involves broad, systemic suppression of myostatin to study whole-body muscle hypertrophy
+Study design focuses on chronic muscle-wasting conditions where systemic intervention is more relevant
+Interest in the intersection of muscle growth and metabolic health markers such as body fat reduction

Choose MGF when:

+Research goal is to examine localized muscle repair and satellite cell activation following mechanical stress or exercise
+Study design requires targeted delivery to a specific muscle group to isolate hypertrophic response
+Focus is on acute post-exercise recovery windows and reducing markers of muscle damage in the short term

Stacking Follistatin with MGF is explored in some research contexts because their mechanisms are complementary: Follistatin removes the systemic ceiling on muscle growth while MGF drives localized satellite cell activation, potentially producing additive hypertrophic effects.

Frequently Asked Questions

Do Follistatin and MGF work through overlapping pathways, or are they entirely independent?⌄

Their pathways are largely independent but converge on the shared outcome of increased muscle protein synthesis. Follistatin acts upstream by neutralizing myostatin, a TGF-beta family member, while MGF signals through IGF-1 receptor-related pathways to activate satellite cells locally. Because they engage different upstream targets, combining them is not expected to cause direct mechanistic interference, though interaction data in humans remains limited.

Which peptide produces faster observable effects in muscle-focused research protocols?⌄

MGF is generally associated with a more acute response window, with satellite cell activation and localized protein synthesis changes observed within days of mechanical stress in preclinical models. Follistatin's effects on muscle mass tend to unfold over longer timeframes as myostatin suppression accumulates. Researchers focused on short-term recovery endpoints may find MGF timelines more aligned with their study design, while Follistatin suits longer-duration hypertrophy protocols.

Can Follistatin and MGF be stacked, and is there evidence supporting this approach?⌄

Stacking these two compounds is theoretically supported by their complementary mechanisms: Follistatin reduces the systemic inhibition of muscle growth, while MGF promotes localized satellite cell recruitment and myoblast differentiation. Some preclinical research suggests additive effects when both myostatin inhibition and IGF-1 splice variant signaling are active simultaneously. However, controlled human data on combined use does not currently exist, and both remain strictly research-only compounds.

If the research goal is whole-body muscle composition change rather than site-specific hypertrophy, which peptide is more appropriate?⌄

Follistatin is more appropriate for whole-body muscle composition research because its myostatin-inhibiting activity is systemic rather than localized. Animal studies have demonstrated substantial increases in total muscle mass across multiple muscle groups following Follistatin administration. MGF, by contrast, exerts its primary effects near the administration site and is better suited to studies examining localized adaptation rather than global changes in lean body mass.

Not sure which fits your research goals?

Use the Goal Finder

Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.

Find My Peptide →

More Comparisons

bpc 157 vs tb 500 mots c vs semaglutide dsip vs melanotan ii retatrutide vs tirzepatide cjc 1295 vs ipamorelin